The 23andMe hacking saga has a new development, courtesy of a multi-million dollar payout to its victims.
On Tuesday, July 7, a U.S. bankruptcy judge ordered 23andMe’s parent company, Chrome Holding, to pay $46.75 million in compensation for the 2023 hack. The number includes $14.29 million previously distributed, Reuters reports.
The genetic testing company, which once had a $6 billion valuation, filed for Chapter 11 bankruptcy in early 2025.
The total sum will be paid to Kroll Restructuring Administration, which will then distribute it to the victims. Up to 6.9 million individuals saw their data compromised in the breach, but the exact number receiving a payout is unclear.
Fast Company has reached out to Kroll Restructuring Administration and 23andMe for more information. We will update this post if we hear back.
What is happening with 23andMe now?
As of today, 23andMe is still selling DNA tests on its website. Last year, Chrome Holding outbid Regeneron Pharmaceuticals—to the tune of $305 million—for 23andMe, under the genetics company’s co-founder, Anne Wojcicki. Chrome Holding operates as the TTAM Research Institute.
Tuesday’s decision doesn’t fully wrap up 23andMe’s fallout from the hack. In May, California Attorney General Rob Bonta sued Chrome Holding “for failing to protect its customers’ sensitive personal information and genetic data related to their health, genetic predispositions and risk factors, biological relatives, ancestry, and ethnicity.” The suit further claims that 23andMe “misled” customers about certain parts of the breach.